ZEPP HEALTH CORP-ADR (ZEPP) Stock Price, Quote, News and Overview
NYSE:ZEPP - New York Stock Exchange, Inc. - US98945L2043 - ADR - Currency: USD
ZEPP Quote, Performance and Key Statistics
2.97
-0.02 (-0.67%)
The current stock price of ZEPP is 2.97 USD. In the past month the price decreased by -1%. In the past year, price decreased by -37.08%.
ZEPP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| KEYS | KEYSIGHT TECHNOLOGIES IN | 28.03 | 30.34B | ||
| TDY | TELEDYNE TECHNOLOGIES INC | 24.86 | 22.88B | ||
| TRMB | TRIMBLE INC | 25.08 | 17.57B | ||
| ZBRA | ZEBRA TECHNOLOGIES CORP-CL A | 23.02 | 16.04B | ||
| BMI | BADGER METER INC | 49.7 | 6.18B | ||
| VNT | VONTIER CORP | 13 | 5.66B | ||
| CGNX | COGNEX CORP | 44.3 | 5.62B | ||
| NOVT | NOVANTA INC | 47.63 | 5.05B | ||
| AEIS | ADVANCED ENERGY INDUSTRIES | 34.11 | 4.77B | ||
| ITRI | ITRON INC | 17.02 | 4.24B | ||
| MIR | MIRION TECHNOLOGIES INC | 38.59 | 3.67B | ||
| OSIS | OSI SYSTEMS INC | 23.33 | 3.40B |
Related stock screener links
About ZEPP
Company Profile
Zepp Health Corp is a CN-based company operating in Electronic Equipment, Instruments & Components industry. The company is headquartered in Hefei, Anhui and currently employs 839 full-time employees. The company went IPO on 2018-02-08. Zepp Health Corp, formerly Huami Corp, is a company committed to connect health with technology. The company has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. The company is engaged in developing smart wearable technology. The company designs and develops biometric and activity data-driven fitness and smart watches. The company markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. The company also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.
Company Info
ZEPP HEALTH CORP-ADR
Building B2, Zhong'an Chuanggu Technology Park, No.900 Wangjiang West Rd
Hefei ANHUI 230088 CN
CEO: Wang Huang
Employees: 839
Company Website: http://www.huami.com
Investor Relations: https://ir.zepp.com/
Phone: 8655165837200
ZEPP HEALTH CORP-ADR / ZEPP FAQ
What is the stock price of ZEPP HEALTH CORP-ADR today?
The current stock price of ZEPP is 2.97 USD. The price decreased by -0.67% in the last trading session.
What is the ticker symbol for ZEPP HEALTH CORP-ADR stock?
The exchange symbol of ZEPP HEALTH CORP-ADR is ZEPP and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is ZEPP stock listed?
ZEPP stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for ZEPP HEALTH CORP-ADR stock?
7 analysts have analysed ZEPP and the average price target is 14.94 USD. This implies a price increase of 403.13% is expected in the next year compared to the current price of 2.97. Check the ZEPP HEALTH CORP-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ZEPP HEALTH CORP-ADR worth?
ZEPP HEALTH CORP-ADR (ZEPP) has a market capitalization of 178.14M USD. This makes ZEPP a Micro Cap stock.
How many employees does ZEPP HEALTH CORP-ADR have?
ZEPP HEALTH CORP-ADR (ZEPP) currently has 839 employees.
What are the support and resistance levels for ZEPP HEALTH CORP-ADR (ZEPP) stock?
ZEPP HEALTH CORP-ADR (ZEPP) has a support level at 2.96 and a resistance level at 2.97. Check the full technical report for a detailed analysis of ZEPP support and resistance levels.
Should I buy ZEPP HEALTH CORP-ADR (ZEPP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ZEPP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ZEPP, evaluating the profitability, health, valuation and growth aspects
- ZEPP HEALTH CORP-ADR (ZEPP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ZEPP HEALTH CORP-ADR (ZEPP) Sales and EPS estimates to see what analysts future expectations are.
- ZEPP HEALTH CORP-ADR (ZEPP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ZEPP HEALTH CORP-ADR (ZEPP) Insider and Institutional Ownership to learn about the owners and their transactions.
- ZEPP HEALTH CORP-ADR (ZEPP) Stock Chart to make your own analysis
- ZEPP HEALTH CORP-ADR (ZEPP) Latest news and press-releases to stay up to date.
Does ZEPP HEALTH CORP-ADR (ZEPP) stock pay dividends?
ZEPP does not pay a dividend.
When does ZEPP HEALTH CORP-ADR (ZEPP) report earnings?
ZEPP HEALTH CORP-ADR (ZEPP) will report earnings on 2025-03-17, after the market close.
What is the Short Interest ratio of ZEPP HEALTH CORP-ADR (ZEPP) stock?
The outstanding short interest for ZEPP HEALTH CORP-ADR (ZEPP) is 0.06% of its float. Check the ownership tab for more information on the ZEPP short interest.
ZEPP Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ZEPP. When comparing the yearly performance of all stocks, ZEPP is a bad performer in the overall market: 75.86% of all stocks are doing better.
ZEPP Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ZEPP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ZEPP. The Buy consensus is the average rating of analysts ratings from 7 analysts.